Related Experiment Video
Updated: Jun 12, 2025
08:01
Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
28.0K
Invasive pulmonary aspergillosis in patients with acute leukemia
Olfa Kassar1, Aicha Ben Kahla1, Yosra Fakhefakh1
1Department of hematology University Hedi Chaker Hospital Faculty of Medecine Sfax, University of Sfax.
La Tunisie Medicale
|September 17, 2024
Summary
Invasive pulmonary aspergillosis (IPA) in acute leukemia patients has high morbidity and mortality. Early diagnosis and improved management strategies are crucial for better outcomes in hematology patients.
Area of Science:
- Hematology
- Infectious Diseases
- Pulmonology
Background:
- Invasive pulmonary aspergillosis (IPA) is a significant complication in hematology patients.
- Acute leukemia patients are particularly vulnerable to IPA.
- High morbidity and mortality rates are associated with IPA in this population.
Purpose of the Study:
- To describe the prevalence of IPA in acute leukemia patients.
- To analyze diagnostic aspects, therapeutic modalities, and outcomes of IPA.
- To evaluate the evolution of IPA cases in hematology patients.
Main Methods:
- Retrospective study of acute leukemia patients with IPA from January 2009 to December 2020.
- IPA diagnosis based on EORTC/MSG 2019 criteria.
- Data collection included clinical presentation, imaging (CT scan), serology (Aspergillus galactomannan), and treatment response.
Main Results:
- 127 IPA cases identified, 63% in acute myeloid leukemia patients.
- IPA diagnosed during induction chemotherapy in 76% of cases.
- Halo sign on CT (89%), positive galactomannan (38%), extrapulmonary involvement (18%).
- Voriconazole treatment showed a 54% favorable response rate.
- Mortality rate was 46%, with 56% survival at 12 weeks.
Conclusions:
- IPA in acute leukemia patients carries a high burden of disease.
- Current diagnostic and therapeutic strategies require enhancement.
- There is a critical need for improved early detection and management protocols for IPA in hematology.
Related Concept Videos
01:30Pneumonia I: Introduction
214
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
214
01:29Pulmonary Tuberculosis I
224
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
224
01:25Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
01:27Disorders of Leukocytes
903
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
903
01:22Bone Marrow Sampling and Transplants
313
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
313